Dachaigh › Galaran sgamhain eadar-fhillte › New York › New York City
Sgrùdaidhean clionaigeach Galaran sgamhain eadar-fhillte ann an New York City, NY
Tha 18 sgrùdaidhean airson Galaran sgamhain eadar-fhillte a’ lorg phàirtichean aig làraichean ann agus timcheall air New York City (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
A’ fastadhÌre 3
- Weill Cornell Medicine-New York-60569, New York
- Columbia University Medical Center-New York Presbyterian Hospital, New York
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
A’ fastadhÌre 3
- Weill Cornell Medicine-New York-60569, New York
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
A’ fastadhÌre 2
- NYU Langone Health, New York
- Icahn School of Medicine at Mount Sinai, New York
- Weill Cornell Medicine, New York
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
A’ fastadhÌre 3
- USA005, New York
A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
A’ fastadhÌre 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
A’ fastadhÌre 3
- GSK Investigational Site, New York
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
A’ fastadhÌre 3
- GSK Investigational Site, New York
- GSK Investigational Site, New York
- GSK Investigational Site, New York
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
A’ fastadhÌre 2/3
- GSK Investigational Site, New York
- GSK Investigational Site, New York
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
A’ fastadhÌre 2
- Icahn School of Medicine at Mount Sinai, New York
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
A’ fastadh
- Weill Cornell University Medical College, New York
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
A’ fastadhÌre 3
- NYU Langone Health, New York
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
A’ fastadhSgrùdadh amharc
- New York University Langone Medical Center, New York
- New York Presbyterian Hospital - Weill Cornell Medicine, New York
PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
A’ fastadhSgrùdadh amharc
- Weill Cornell Medicine, New York
Platform Clinical Study for Conquering Scleroderma
A’ fastadhÌre 2
- Hospital for Special Surgery, New York
- Columbia University Medical Center, New York
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
A’ fastadhÌre 2/3
- Columbia University Irving Medical Center, New York
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
A’ fastadhSgrùdadh amharc
- Weill Medical College of Cornell University, New York
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
A’ fastadhÌre 3
- Weill Cornell Medicine, New York-Presbyterian Hospital, New York
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
A’ fastadhÌre 2
- aTyr Investigative Site, New York
Sgrùdaidhean Galaran sgamhain eadar-fhillte ann am bailtean eile
- Philadelphia, PA16 sgrùdaidhean
- Los Angeles, CA14 sgrùdaidhean
- Charleston, SC13 sgrùdaidhean
- Kansas City, KS13 sgrùdaidhean
- Durham, NC13 sgrùdaidhean
- Chicago, IL12 sgrùdaidhean
- Houston, TX12 sgrùdaidhean
- Aurora, CO11 sgrùdadh
- Ann Arbor, MI11 sgrùdadh
- Salt Lake City, UT9 sgrùdaidhean
- Dallas, TX9 sgrùdaidhean
- Boston, MA9 sgrùdaidhean
Sgrùdaidhean eile ann an New York City
- Aillse a' bhroilleach136 sgrùdaidhean
- Aillse Sgamhain Neo-chealla-beag121 sgrùdaidhean
- Aillse (gach seòrsa)109 sgrùdaidhean
- Aillse Prostata103 sgrùdaidhean
- Ailse metastatach93 sgrùdaidhean
- Aillse colorectal78 sgrùdaidhean
- Cancer Ovarian69 sgrùdaidhean
- Ailseachadh nan Sgamhan60 sgrùdaidhean
- Myeloma iomaill60 sgrùdaidhean
- Cancer Pancreatic60 sgrùdaidhean
- Ailse Endometrial52 sgrùdaidhean
- Leukemia myeloid geur51 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.